Telerehabilitation Cognitive Impairments Following Chemotherapy Feasibility Study
Public ClinicalTrials.gov record NCT04972019. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Home-based Virtual Reality System for the Treatment of Chemotherapy-related Cognitive Impairments - Feasibility Study
Study identification
- NCT ID
- NCT04972019
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Bright Cloud International Corp
- Industry
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Interventions
- Telerehabilitation Experimental Group Device
- Telerehabilitation Sham Control Group Other
Device · Other
Eligibility (public fields only)
- Age range
- 20 Years to 65 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 8, 2022
- Primary completion
- Sep 29, 2022
- Completion
- Sep 29, 2022
- Last update posted
- May 1, 2022
2022
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rutgers University Rober Wood Johnson Medical School | New Brunswick | New Jersey | 08901 | Recruiting |
| Bright Cloud Int'l Corp | North Brunswick | New Jersey | 08902 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04972019, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 1, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04972019 live on ClinicalTrials.gov.